HOME > RESOURCES > COMPANY PROFILES > ALNYLAM PHARMACEUTICALS INC

Alnylam Pharmaceuticals Inc (ALNY)

Dr. John M. Maraganore, Ph.D.,

(617) 551-8101

Industry: Healthcare

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

News

New pre-clinical data from Alnylam Pharmaceuticals' ALN-VSP program presented (News-Medical-Net)

2009/11/18
Frost & Sullivan honors excellence in healthcare innovation (News-Medical-Net)

2009/11/23
Press conference highlights emerging treatments in pancreatic cancer (News-Medical-Net)

2009/11/18

Visit our partner sites

Get Local News From bizjournals:

Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions. Company fundamental data provided by Hemscott. Economic data provided by Econoday. News provided by Comtex. Sec Filings data provided by Edgars. The Wall Street Horizon National Consumer Interest Rate Survey. ©2009 Wall Street Horizon. PMMS Mortgage Data ©2009 Freddie Mac. Mortgage averages are for conforming mortgages with 20% down.

Alnylam Pharmaceuticals Inc (ALNY)

News

Visit our partner sites

BizJournals

Get Local News From bizjournals:

Visit Condé Nast Digital sites: